ExpertiseUpdated on 28 April 2026
Nanobody engineering and translational biologics development
About
NanoVet brings deep expertise in nanobody engineering and translational biologics development, integrating target biology, molecular design, and developability considerations to create efficient and scalable therapeutic solutions. Our team combines scientific and commercial experience to bridge early discovery with real-world application, with a particular focus on delivering cost-effective biologics for veterinary markets where traditional antibody approaches are often limited.
Similar opportunities
Investment
Accelerate preclinical and clinical development
Nicolás Galmarini
CEO & Co-founder at NanoVet Biotech
Pamplona, Spain
Partnership
With Animal Health and Biotech companies
Nicolás Galmarini
CEO & Co-founder at NanoVet Biotech
Pamplona, Spain